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Objective: Estrogen interacts with a membrane receptor, G protein-coupled estrogen receptor (GPER). It
was reported that 17b-estradiol was able to inhibit contraction of the human colon and cause relaxation
of the guinea pig gallbladder, however, the involvement of GPER was not clariﬁed. The aim of the present
study was to investigate the effect of estrogen on human gallbladder motility and the possible role of
GPER.
Materials and Methods: Relaxation of human gallbladder strips were measured using isometric trans-
ducers. Expression of GPER was evaluated by reverse transcription polymerase chain reaction (PCR), real-
time PCR, and immunohistochemistry.
Results: In human gallbladder strips, 17b-estradiol and G-1 elicited marked and rapid relaxation,
whereas tamoxifen produced mild concentration-dependent relaxation. The relative efﬁcacies to cause
relaxation were as follows: 17b-estradiol ¼ G-1 > tamoxifen. The relaxant response of 17b-estradiol was
not attenuated by tetrodotoxin or conotoxin GVIA. This implies that nerve stimulation was not involved
in the 17b-estradiol-induced gallbladder relaxation. Analysis by reverse transcription PCR and real-time
PCR showed that GPER was expressed in the human gallbladder. Further analysis by immunohisto-
chemistry revealed that GPER was expressed in the gallbladder muscle. This suggests that 17b-estradiol
relaxes the human gallbladder via GPER.
Conclusion: These results demonstrate for the ﬁrst time that 17b-estradiol and GPER agonist G-1 cause
relaxation of the human gallbladder, probably through GPER. Estrogen might play an important role in
the control of human gallbladder motility.
Copyright © 2016, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Estrogen is an important sex hormone. The action of estrogen is
mediated classically by two nuclear estrogen receptors, ERa and
ERb, which function as ligand-activated transcription factors and
regulate gene expression. Recently, estrogen was found to be adicine, Toyotomicho National
hio-Gun, Hokkaido 098-4121,
Huang).
lief Tzu Chi Foundation. Publishedligand for a membrane receptor, G protein-coupled estrogen re-
ceptor (GPER), formerly known as GPR30 [1e4]. GPER mediates
estrogen-dependent rapid signaling and transcriptional responses.
Expression of GPER has been detected in cardiovascular, gastroin-
testinal, reproductive, and nervous tissues [1e4]. Interestingly,
tamoxifen, which functions as a nuclear estrogen receptor antag-
onist and inhibits the activities of classical estrogen nuclear re-
ceptors, acts as a GPER agonist [1,5]. GPER may play an important
role in the physiology of the reproductive, nervous, endocrine,
immune, and cardiovascular systems as well as in the pathophys-
iology of cancer [1e4]. In the cardiovascular system, estrogen
causes relaxation of vascular smooth muscle through GPER [6e9].by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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vascular diseases [2,3,8,9]. In the gastrointestinal system, estrogen
has been found to inhibit contraction of the human colon and
guinea pig gallbladder as well as rat gastric emptying [10e12].
Females experience gallstones and constipation more frequently
than males [13,14]. Impaired gallbladder motility may contribute to
gallstone formation [15]. To date, GPER-mediated effects of estro-
gen in the gastrointestinal system are not clear [16]. Conversely,
estrogen inhibits contraction of the human colon through unclear
mechanisms. The mechanisms of estrogen action in the guinea pig
gallbladder also remain unclear [17]. Little information is available
on the effects of estrogen on the human gallbladder. The aim of the
present study was to investigate the GPER-mediated effects of es-
trogen on human gallbladder motility.
2. Materials and methods
2.1. Materials
Compounds such as 17b-estradiol, tamoxifen, dimethyl sulf-
oxide (DMSO), and TRIzol reagent were obtained from Sigma-
Aldrich (St. Louis, MO, USA). G-1 {1-[4-(6-bromobenzo[1,3]dioxol-
5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-etha-
none}, G-15 [(3aS*,4R*,9bR*)-4-(6-bromo-1,3-benzodioxol-5-yl)-
3a,4,5,9b-3H-cyclopenta(c)quinolone], and tetrodotoxin were pur-
chased from Tocris Cookson (Avonmouth Bristol, UK). u-Conotoxin
GVIA was obtained from Bachem (Bubendorf, Switzerland). Anti-
human GPER rabbit polyclonal antibody (PAB22000, lot #A61748)
was obtained from Abnova (Taipei City, Taiwan). The polymeric
horseradish peroxidaseelinker antibody conjugate system kit
(Bond Polymer Reﬁne Detection, DS9800) was obtained from Leica
Biosystems (Nussloch, Germany). Reverse transcription polymerase
chain reaction (RT-PCR) primers for human GPER and b-actin were
purchased from Integrated DNA Technologies (Coralville, IA, USA).
Klenow fragment was obtained from Level Biotechnology (New
Taipei City, Taiwan). HincII was purchased from New England Bio-
labs (Hitchin, UK). The RNeasy Mini Kit (RNA puriﬁcation kit) was
purchased from Qiagen (Hilden, Germany). The RapidOut DNA
Removal Kit, cDNA reverse transcriptase (RevertAid H Minus
Reverse Transcriptase and High-Capacity cDNA Reverse Transcrip-
tion Kit), and real-time PCR TaqMan primer/probe sets were pur-
chased from Life Technologies (Grand Island, NY, USA).
2.2. Methods
The protocol for this work was approved by the Research Ethics
Committee of Buddhist Tzu Chi General Hospital, Hualien, Taiwan
(IRB100-93, November 1, 2011). The study was performed in
accordance with institutional ethical standards and the Helsinki
Declaration. Human gallbladder tissues were obtained from 37
patients (22 men and 15 women, median age 59 years, range
28e80 years) undergoing surgery for gallstones (14 patients) or
hepatocellular carcinoma (23 patients). Informed consent was ob-
tained from the participants. Immediately after surgical removal of
the gallbladder, a 3 cm  5 cm section of tissue was excised from
the middle portion of each gallbladder corpus and placed in
oxygenated standard incubation solution for transportation to the
laboratory, where the contraction and relaxation experiments were
promptly initiated or tissues were frozen for other experiments.
2.2.1. Measurement of contraction and relaxation of isolated human
gallbladder strips
Measurements of contraction and relaxation of muscle strips
from the human gallbladder were performed according to pro-
cedures described previously [18,19]. In brief, human gallbladdermuscle strips (1.0 cm 0.3 cm) were suspended in organ baths and
incubated at 37C in standard incubation solution (118mM NaCl,
25mM NaHCO3, 4.7mM KCl, 14mM glucose, 1.2mM NaH2PO4,
1.8mM CaCl2, pH 7.4) gassed with 95% O2e5% CO2. The strips were
connected to isometric transducers (FT.03; Grass Technologies,
West Warwick, RI, USA), which were connected to ampliﬁers and a
computer recording system (BIOPAC Systems, Goleta, CA, USA).
Agents related to 17b-estradiol were added in a noncumulative
fashion, i.e., with single dose administration. For measurements of
relaxation in carbachol-precontracted strips, estrogen-related
agents were added to muscle strips 15 minutes after the addition
of carbachol. The relaxation responses were represented as a per-
centage (% papaverine) of the relaxation to 100mM papaverine. For
studies using the receptor antagonist (G-15) and toxins (tetrodo-
toxin andu-conotoxin GVIA), themuscle strips were exposed to the
indicated concentration of these agents for 6 minutes and 15 mi-
nutes, respectively, and then to 17b-estradiol. Only one single-dose
response, with or without a toxin or receptor antagonist, was
studied with each preparation. 17b-estradiol, G-1, tamoxifen, and
G-15 were dissolved in 100% DMSO and then serially diluted in
DMSOewater mixtures. The ﬁnal concentrations of DMSO were
1% in the gallbladder relaxation studies.
2.2.2. T-PCR for detection of mRNA of GPER in the human
gallbladder
RT-PCR for the detection of the mRNA of GPERwas performed as
described previously with minor modiﬁcations [18,19]. Total RNA
was isolated from the human gallbladder muscle using the TRIzol
reagent, treated with RNase-free DNase I to remove genomic DNA
contamination and reverse transcribed into cDNA using the
RevertAid HMinus Reverse Transcriptase. The PCR ampliﬁcation for
GPER was performed in the GeneAmp PCR System 9700 (Applied
Biosystems/Life Technologies, Grand Island, NY, USA) with Taq
polymerase for one cycle at 94C for 2 minutes, followed by 30
cycles at 94C for 30 seconds, 55C for 30 seconds, and 72C for
30 seconds, and, ﬁnally at 72C for 5 minutes. After ampliﬁcation,
the PCR products were subjected to electrophoresis on a 1.5%
agarose gel, which was stained with ethidium bromide and
analyzed under UV light. The sequences of primers for human GPER
were as follows: sense 50-CTGCACGAGCGGTACTACGA-30 and anti-
sense 50-CAGATGAGGCCACAGCTCAG-30 (PCR product size 191 base
pairs) [20]. b-Actin was used as an internal control. The sequences
of primers for human b-actin were as follows: sense 50-
CACTCTTCCAGCCTTCCTTC-30and antisense 50-CTCGTCA-
TACTCCTGCTTGC-30 (PCR product size 314 base pairs) [21]. The PCR
ampliﬁcation for b-actin was performed with Taq polymerase for
one cycle at 94C for 5 minutes, followed by 35 cycles at 94C for
30 seconds, 62C for 1 minute, 72C for 1 minute, and ﬁnally 72C
for 5 minutes. For sequencing, the GPER PCR products were blunt
ended by treating with Klenow fragment and ligated into the HincII
cut pOk12 vectors. The ligation mixture was used to transform
Escherichia coli strain Top10 to produce permanent clones for
sequencing at Genomics BioSci & Tech (New Taipei City, Taiwan).
2.2.3. Real-time PCR for detection of mRNA of GPER in the human
gallbladder
Total RNAwas isolated from human gallbladder muscle using an
RNA puriﬁcation kit (RNeasy Mini Kit; Qiagen), treated with a re-
combinant DNase I (RapidOut DNA Removal Kit: Life Technologies),
and reverse transcribed into cDNA with a recombinant Moloney
murine leukemia virus reverse transcriptase (High-Capacity cDNA
Reverse Transcriptase Kit; Life Technologies). The real-time PCR for
detection of GPER mRNA was performed using the TaqMan Gene
Expression Assay (Life Technologies) following the procedure
described previously with minor modiﬁcations [22]. Real-time PCR
Fig. 1. Typical tracings showing the relaxation of carbachol-precontracted human
gallbladder strips caused by 17b-estradiol (upper panel) and G-1 (lower panel).
Fig. 2. The ability of 17b-estradiol, G-1, and tamoxifen to cause relaxation of human
gallbladder strips precontracted with carbachol (1mM). Values are expressed as percent
of papaverine (100mM)-induced relaxation. The results given are from at least four
experiments. Vertical bars represent ± standard error of the mean. * Signiﬁcant dif-
ference from DMSO vehicle (ANOVA; p < 0.05). # Signiﬁcant difference from tamoxifen
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systems/Life Technologies) and the speciﬁc primer/probe set for
GPER (Hs01922715_s1). Two housekeeping genes, GAPDH (glycer-
aldehyde-3-phosphate dehydrogenase, Hs02758991_g1) and b-
actin (Hs01060665_g1), were used as endogenous controls to
standardize the amount of cDNA. The thermal cycling conditions
were one cycle of 2 minutes at 50C and one cycle of 10 minutes at
95C, followed by 40 cycles of ampliﬁcation for 15 seconds at 95C
and 1 minute at 60C. Cycle threshold values were obtained, and
quantiﬁcation was carried out by the relative expression method
using the geometric mean of two reference genes, GAPDH and b-
actin. Control reactions with no reverse transcriptase added were
performed in each experiment to determine that ampliﬁcation was
derived from the cDNA and not from genomic DNA contamination.
2.2.4. Immunohistochemistry for detection of GPER in the human
gallbladder
To localize GPER in the human gallbladder, immunohisto-
chemistry was performed as previously described with minor
modiﬁcations [23]. Immunohistochemical staining was performed
using an automated staining system (BOND-MAX; Leica Micro-
systems, Nussloch, Germany). Brieﬂy, parafﬁnized human gall-
bladder tissue sections of 4 mmwere deparafﬁnized, hydrated, and
subjected to heat-induced antigen retrieval with citrate buffer, pH
6.0. The staining procedure involved peroxidase blocking with 3%
hydrogen peroxide for 5 minutes, and sequential applications of the
primary GPER antibody (1 mg/mL) for 30 minutes and an antirabbit
horseradish peroxidase polymer for 8 minutes at room tempera-
ture. Subsequently, the tissue sections were treated with a chro-
mogen, 3,30-diaminobenzidine for 10 minutes and counterstained
with hematoxylin for 5 minutes at room temperature. Normal
rabbit immunoglobulin G (1 mg/mL) was used as a negative control.
2.2.5. Analysis of data
Results are expressed as mean values ± standard error of the
mean. Statistical evaluationwas performed using unpaired Student
t test for two samples or one-way analysis of variance using Dun-
nett's procedure for more than two samples. A p value < 0.05 was
considered statistically signiﬁcant.(ANOVA; p < 0.05). ANOVA ¼ analysis of variance; DMSO ¼ dimethyl sulfoxide.3. Results
3.1. Effects of estrogen-related agents on human gallbladder strips
To test the ability of estrogen-related agents to cause human
gallbladder relaxation, muscle strips of human gallbladder were
prepared and responses to 17b-estradiol, G-1, and tamoxifen were
studied. Addition of 17b-estradiol and G-1 to the gallbladder strips
precontracted with carbachol (1mM) caused marked, rapid, and
concentration-dependent relaxation (Figs. 1 and 2). At 1mM, 17b-
estradiol caused detectable relaxation of the carbachol-
precontracted gallbladder strips. The highest concentration of
17b-estradiol tested, 100mM, produced 52 ± 8% (n ¼ 7) relaxation
of papaverine (100mM)-induced relaxation. In contrast, the vehicle
DMSO caused only 23 ± 5% (n ¼ 4) of papaverine-induced relax-
ation (Fig. 2). Similarly, G-1 caused detectable relaxation of the
carbachol-precontracted human gallbladder strips at 1mM. The
highest concentration of G-1 tested, 100mM, produced 48 ± 6%
(n ¼ 4) relaxation of papaverine-induced relaxation. Tamoxifen
was less effective than 17b-estradiol and G-1, and caused detect-
able relaxation of the carbachol-precontracted human gallbladder
strips at 10mM. At 30mM, tamoxifen produced 23 ± 4% (n ¼ 4)
relaxation of the human gallbladder (Fig. 2). The relative efﬁcacies
for estrogen-related agents to cause relaxation of carbachol-precontracted gallbladder were as follows: 17b-estradiol ¼ G-
1 > tamoxifen. The 17b-estradiol-induced relaxation was not
altered by tetrodotoxin or u-conotoxin GVIA. In the presence of
1mM tetrodotoxin and u-conotoxin GVIA, 17b-estradiol (30mM)
produced 33 ± 6% (n ¼ 5) and 31 ± 2% (n ¼ 4) papaverine-induced
relaxation of carbachol-precontracted human gallbladder, respec-
tively (p ¼ 0.38 and p ¼ 0.26, respectively, compared with 17b-
estradiol alone, 36 ± 2%, n ¼ 11). At 3mM, G-15, a GPER receptor
antagonist [1], could inhibit human gallbladder relaxation caused
by 17b-estradiol (30mM), but it was not of statistical signiﬁcance
(data not shown).3.2. RT-PCR analysis of GPER expression in the human gallbladder
RT-PCR was used to examine mRNA expression of GPER in the
human gallbladder. As shown in Fig. 3, ampliﬁcation of human
gallbladder cDNA yielded the predicted 191 base-pair product for
GPER (n¼ 3) [20]. In addition, sequencing of the GPER PCR products
and blasting against the National Center for Biotechnology Infor-
mation nucleotide database revealed that the following PCR prod-
ucts represented a partial sequence of human GPER.
Nucleotide sequence of the GPER PCR products:
Fig. 3. Reverse transcription polymerase chain reaction analysis of expression of GPER
mRNA in the human gallbladder. Total RNA was reverse transcribed and ampliﬁed
using GPER and b-actin speciﬁc primers. The ampliﬁed products were electrophoresed
on agarose gel, stained with ethidium bromide, and analyzed under UV light. The
results presented are representative of three experiments. Lane M represents molec-
ular weight markers; Lane 1, GPER; and Lane 2 b-actin. GPER ¼ G protein-coupled
estrogen receptor.
Fig. 4. Real-time PCR analysis of GPER mRNA expression in the human gallbladder. The
relative GPER expression levels in human gallbladders from women and men were
calculated using the comparative Ct method and normalized against two housekeeping
genes, glyceraldehyde 3-phosphate dehydrogenase and b-actin. Vertical bars
represent ± standard error of the mean (n ¼ 3/group). Ct ¼ cycle threshold; GPER ¼ G
protein-coupled estrogen receptor; PCR ¼ polymerase chain reaction.
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ACAGGCTGCAGCGCATGGCCCTGGCCAGGGCGATGTAGCGGTCGAA-
GCTCATCCAGGTGAGGAAGAAGACGCTGCTGTACATGTTGACCTGC-
AGGAAGAGCGACATGAAGGTGCACAGGACGGCGATG TCGTAGTAC-
CGCTCGTGCA…30 (Sections in bold indicate sequences of primers,
partially excised.)3.3. Real-time PCR analysis of GPER expression in the human
gallbladder
The relative mRNA expressions of GPER in the human gall-
bladder are shown in Fig. 4. Real-time PCR analysis showed that theFig. 5. Microscopic images (100) showing (A) immunohistochemical localization of GPER i
control with normal rabbit immunoglobulin G. The results presented are representative ofrelative expression levels of GPER were 0.40 ± 0.08  103 and
0.46 ± 0.12 103 for human gallbladders fromwomen (n¼ 3) and
men (n ¼ 3), respectively.3.4. Immunohistochemical analysis of GPER expression in the
human gallbladder
In the immunohistochemical study, GPER was detected in the
smooth muscle of the human gallbladder (Fig. 5A). In contrast, in-
cubation of the human gallbladder with nonimmune rabbit
immunoglobulin G followed by the secondary antibody complex
resulted in a lack of staining (Fig. 5B).4. Discussion
Previous studies showed that 17b-estradiol causes relaxation of
the human colon and guinea pig gallbladder [10,12]. However, the
role of GPER in the relaxation of the gallbladder and colon was not
clear. The present study provides the ﬁrst evidence that GPER-
related agents, such as 17b-estradiol and G-1, can cause relaxa-
tion of the human gallbladder. In addition, we demonstrated the
expression of GPER in the human gallbladder.
G-1 is a GPER-selective agonist and does not bind to estrogen
nuclear receptors [1,5,24]. Tamoxifen is an estrogen nuclear re-
ceptor antagonist but a weak GPER agonist [1,5]. In the human
gallbladder, 17b-estradiol and G-1 elicited a marked and fast
relaxation, while tamoxifen produced a mild relaxation. This in-
dicates that GPER mediates the relaxant response. The existence of
GPER in the human gallbladder was conﬁrmed by immunohisto-
chemistry, RT-PCR, and real-time PCR. Thus, the present study
demonstrates that 17b-estradiol may cause relaxation of the hu-
man gallbladder via GPER. However, G-15, a GPER receptor antag-
onist [1], could inhibit the human gallbladder relaxation caused by
17b-estradiol, but not with statistical signiﬁcance. More potent
GPER antagonists are needed to further clarify the involvement of
GPER in human gallbladder motility.
In human gallbladder strips, the ability of 17b-estradiol to cause
relaxation was not altered by tetrodotoxin and u-conotoxin GVIA.
This suggests that 17b-estradiol interacts directly with receptors on
the gallbladder smooth muscle to cause the relaxation.
Natriuretic peptides, bile salts, pituitary adenylate cyclase-
activating peptide, and vasoactive intestinal peptide have been
reported to cause relaxation of the human and guinea pig gall-
bladder [17,19]. The present study demonstrates that 17b-estradiol
causes relaxation of the human gallbladder. Estrogen might play an
important role in regulating the muscle tone of the human gall-
bladder. GPER antagonists, which may increase gallbladder musclen the human gallbladder muscle. (B) No immunostaining was observed in the negative
three experiments. Scale bar ¼ 100 mm. GPER ¼ G protein-coupled estrogen receptor.
M.-C. Lee et al. / Tzu Chi Medical Journal 28 (2016) 54e5858tone, might be of potential therapeutic value in gallstone disease. In
human colon strips, 17b-estradiol was reported to interact with a
membrane receptor, which might be GPER [10]. Therefore, it is
likely that estrogen may modulate human gastrointestinal and
hepatobiliary tract motility via GPER.
Gallbladder motility is involved in the pathogenesis of gallstone
formation [15,25]. From our ex vivo study, GPER might mediate the
relaxation of human gallbladder, and GPER probably expresses in
the human gallbladder of both women and men. It is not clear
whether there are potential differences in gallbladder expression of
GPER and estrogen-induced gallbladder relaxant responses be-
tween the two sexes. Further studies, including estrogen-induced
human gallbladder relaxation in vivo, are needed to clarify the
possible involvement of GPER in gallstone formation.
In conclusion, our results demonstrate for the ﬁrst time that
17b-estradiol and GPER agonist G-1 cause relaxation of the human
gallbladder, probably through GPER. Estrogen might play an
important role in the control of human gallbladder motility.
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